ADVISORY/Press Conference Scheduled to Discuss Parkinson's Disease Patient Research Findings Prior to American
Neurological Association Annual Meeting.
SAN FRANCISCO, Oct 16, 2003 (BUSINESS WIRE) -- Results of the "Impact of Parkinson's Disease on the Quality of Life"
patient-based research study will be revealed in a breakfast panel discussion on Monday, October 20, 2003, from 7:00 -
8:00 a.m. Pacific. The discussion is occurring as neurologists gather in San Francisco for the American Neurological
Association's annual meeting, October 19 - 22.
The study was commissioned by Amarin Pharmaceuticals (www.amarinpharma.com), sponsored by WE MOVE (Worldwide Education
and Awareness for Movement Disorders, www.wemove.org) and conducted by the Harris Interactive market research group
(www.harrisinteractive.com). Data from a sample of 228 Parkinson's disease patients were obtained during online survey
fielding August - September 2003. Covered topics include the debilitating effects of "OFF" time, patient's lifestyle
modifications, levels of satisfaction with current treatment options, and desired changes for future Parkinson's
disease medications.
Panel discussion participants will be:
-- William Koller, MD, PhD, Professor of Neurology, Mt. Sinai
School of Medicine (New York, NY)
-- Matthew B. Stern, MD, Parker Family Professor of Neurology and
Director, Parkinson's Disease and Movement Disorders Center,
University of Pennsylvania Health System (Philadelphia, PA)
-- Ray Watts, MD, Chairman of Neurology, University of Alabama at
Birmingham (Birmingham, AL)
-- Judith Blazer, MS, Executive Director, WE MOVE
-- Lori Stone, PhD, Senior Research Associate, Harris Interactive
WHAT: Panel discussion of survey results: "Impact of Parkinson's
Disease on the Quality of Life"
WHO: Movement disorder specialists Drs. William Koller, Matthew
Stern and Ray Watts
WE MOVE
Harris Interactive
WHEN: Monday, October 20, 2003
7:00 - 8:00 a.m. Pacific
Interviews available afterward
WHERE: In person: Marriott Hotel, Walnut Room, 55 Fourth Street,
San Francisco, CA
By phone: 888-428-4479; specify "Impact of Parkinson's
Disease on the Quality of Life" teleconference
SOURCE: Amarin Pharmaceuticals
CONTACT: ARiA Marketing, Inc.
Paul Kidwell, 617-296-3854
[log in to unmask]
SOURCE: Macro*World Investor
http://www.mworld.com/m/m.w?lp=GetStory&id=75640261
* * *
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
